Rockwell Medical, Inc., a healthcare company with its subsidiaries, has become a prominent force in the development, manufacture, commercialization, and distribution of a multitude of hemodialysis products for providers globally. This Michigan-based company provides a range of products including Triferic Dialysate and Triferic AVNU for the maintenance of hemoglobin in patients undergoing hemodialysis. Additionally, Rockwell Medical produces a variety of hemodialysis concentrates including CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, and more. The company's dialysis concentrate products are vital to the removal of toxins and replacement of critical nutrients in the dialysis patient's bloodstream, thereby contributing to the preservation of human life. Rockwell Medical is also developing therapeutic product candidates for the treatment of hospitalized patients with acute heart failure, and home infusion therapy for the administration of intravenous medications at home. The company's target customers are medium and small-sized dialysis chains and independent dialysis centers worldwide. Incorporated in 1996, Rockwell Medical, Inc. is headquartered in Wixom, Michigan.